Approved vaccines in Canada: Reporting Adverse Events Following Immunization (AEFI)
| Vaccine | Trade name | Abbreviation | Market authorization holderTable 1 Footnote 1 |
|---|---|---|---|
| Chikungunya Vaccine, live, attenuated | IXCHIQ | Chik | VCI |
| Inactivated Cholera and LT-producing ETEC Diarrhea Vaccine | Dukoral® | Chol-Ecol-O | VCI |
| Cholera Vaccine, Live Attenuated, Oral | VAXCHORA® | Chol-O | ETH |
| COVID-19 mRNA vaccine, Omicron KP.2 variant | COMIRNATY® (Omicron KP.2 variant) | COVID-19 | PB |
| COVID-19 Vaccine (Recombinant protein, Adjuvanted), Omicron JN.1 variant | NUVAXOVID™ (Omicron JN.1 variant) | Nova | |
| COVID-19 mRNA vaccine, Omicron KP.2 variant | SPIKEVAX® (Omicron KP.2 variant) | Mod | |
| Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed | Tripacel® | DTaP | SP |
| Adsorbed Hib reconstituted with PEDIARIX. Combined Diphtheria and Tetanus Toxoids, Acellular Pertussis, Hepatitis B (recombinant), Inactivated Poliomyelitis and adsorbed conjugated Haemophilus influenzae type b | INFANRIX hexa® | DTaP-HB-IPV-Hib | GSK |
| Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine | QUADRACEL® | DTaP-IPV | SP |
| HIBERIX® reconstituted with INFANRIX®-IPV. Combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, Haemophilus influenzae type b vaccine | INFANRIX®-IPV/Hib | DTaP-IPV-Hib | GSK |
| Act-HIB® Reconstituted with QUADRACEL®. Haemophilus b Conjugate Vaccine (Tetanus Protein - Conjugate) Reconstituted with Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine | Pentacel® | SP | |
| Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP, live) | ERVEBO® | EZV | Merck |
| Hepatitis A Vaccine Inactivated | Avaxim® | HA | SP |
| Havrix® 1440 | GSK | ||
| Havrix® 720 (Junior) | |||
| Vaqta® | Merck | ||
| Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine | Twinrix® | HAHB | GSK |
| Twinrix® Junior | |||
| Hepatitis B vaccine [recombinant] | Engerix®-B | HB | GSK |
| Engerix®-B (Pediatric dose) | |||
| Recombivax HB® | Merck | ||
| Recombivax HB® (Dialysis) | |||
| 3-antigen Hepatitis B Vaccine (recombinant) | PREHEVBRIO™ | VBI | |
| Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate) | Act-HIB® | Hib | SP |
| Human Papillomavirus 9-valent Vaccine, Recombinant | Gardasil® 9 | HPV-9 | Merck |
| Human Papillomavirus vaccine Types 16 and 18 (Recombinant, AS04 adjuvanted) | Cervarix® | HPV-2 | GSK |
| Trivalent Influenza Vaccine (Split Virion, Inactivated) | Fluviral® | Inf | GSK |
| Influenza Vaccine, Surface Antigen, Inactivated, Adjuvanted with MF59C.1 | Fluad® | Seq | |
| Fluad® Pediatric | |||
| Quadrivalent Inactivated Influenza Vaccine (Split Virion) | Afluria® Tetra | Seq | |
| Quadrivalent Influenza Vaccine (Split Virion, Inactivated) | Flulaval® Tetra | GSK | |
| Influenza Virus Vaccine Trivalent Types A and B (Split Virion) | Fluzone® | SP | |
| Influenza Virus Vaccine Quadrivalent Types A and B (Split Virion) | Fluzone® Quadrivalent | SP | |
| Influenza vaccine, surface antigen, inactivated | Influvac® | BGP | |
| Quadrivalent influenza vaccine, surface antigen, inactivated | Influvac® Tetra | BGP | |
| Influenza Virus Vaccine Trivalent Types A and B (Split Virion) | FLUZONE High-Dose® | SP | |
| AS03-adjuvanted Quebec H5N1 Influenza Vaccine | AREPANRIX™ H5N1 | GSK | |
| High-Dose Quadrivalent Influenza Virus Vaccine - Types A and B (Split Virion) | Fluzone® High-Dose Quadrivalent | SP | |
| Influenza Vaccine (surface antigen, inactivated, prepared in cell cultures) | Flucelvax® | Seq | |
| Influenza Vaccine (surface antigen, inactivated, prepared in cell cultures) | Flucelvax® Quad | Seq | |
| Influenza Vaccine (live, attenuated) | Flumist® Quadrivalent | AZC | |
| Quadrivalent Recombinant Influenza Vaccine. Influenza Virus Type A (H1N1), Type A (H3N2), Type B (Victoria) and Type B (Yamagata) strains | Supemtek™ | SP | |
| Pandemic influenza vaccine (surface antigen, inactivated, adjuvanted with MF59C.1) | FOCLIVIA® | Seq | |
| Pandemic Influenza vaccine (H1N1)v (split virion, inactivated) | PANENZA® | SP | |
| Inactivated Poliomyelitis Vaccine (Vero Cell Origin) | Imovax® Polio | IPV | SP |
| Japanese encephalitis vaccine (inactivated, adsorbed) | IXIARO® | JE | VCI |
| Multicomponent Meningococcal B Vaccine (recombinant, adsorbed) | BEXSERO® | Men-B | GSK |
| Meningococcal group B vaccine [Bivalent recombinant lipoprotein (rLP2086)] | Trumenba® | Pfiz | |
| Meningococcal Group C Conjugate Vaccine | MENJUGATE Liquid | Men-C-C | GSK |
| Meningococcal Group C-TT Conjugate Vaccine, Adsorbed | NeisVac-C® | Pfiz | |
| Meningococcal (Groups A, C, Y, W) Polysaccharide Tetanus Toxoid Conjugate Vaccine | MenQuadfi™ | Men-C-ACYW | SP |
| Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine | Menactra® | Men-C-ACYW-135 | SP |
| Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM 197 Conjugate Vaccine | Menveo™ | GSK | |
| Meningococcal polysaccharide groups A, C, W-135 and Y conjugate vaccine | Nimenrix® | Pfiz | |
| Measles, mumps and rubella virus vaccine, live, attenuated | M-M-R® II | MMR | Merck |
| Combined measles, mumps and rubella vaccine, live, attenuated | PRIORIX® | GSK | |
| Combined measles, mumps, rubella and varicella vaccine, live, attenuated | PRIORIX-TETRA™ | MMR-Var | GSK |
| Measles, Mumps, Rubella and Varicella Virus Vaccine Live | ProQuad® | Merck | |
| Pneumococcal conjugate vaccine (Non-Typeable Haemophilus influenzae (NTHi) protein D, diphtheria or tetanus toxoid conjugates) adsorbed | SYNFLORIX® | Pneu-C-10 | GSK |
| Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM 197 Protein) | Prevnar® 13 | Pneu-C-13 | Pfiz |
| Pneumococcal 15-valent Conjugate Vaccine [CRM 197 Protein], adsorbed | VAXNEUVANCE® | Pneu-C-15 | Merck |
| Pneumococcal 20-valent Conjugate Vaccine (Diphtheria CRM 197 Protein) | Prevnar 20™ | Pneu-C-20 | Pfiz |
| Pneumococcal 21-valent conjugate vaccine | CAPVAXIVE® | Pneu-C-21 | Merck |
| Pneumococcal vaccine, polyvalent, MSD Std. | Pneumovax® 23 | Pneu-P-23 | Merck |
| Rabies Vaccine Inactivated (DCO) | Imovax® Rabies | Rab | SP |
| Rabies Vaccine | RabAvert® | BN | |
| Human rotavirus, live, attenuated, oral vaccine | ROTARIX® | Rot-1 | GSK |
| Rotavirus vaccine, live, oral, pentavalent | RotaTeq® | Rot-5 | Merck |
| Respiratory Syncytial Virus (RSV) Vaccine (recombinant, AS01E adjuvanted) | AREXVY | RSV | GSK |
| Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine | ABRYSVO™ | Pfiz | |
| Respiratory Syncytial Virus (RSV) mRNA Vaccine | mRESVIA™ | Mod | |
| Smallpox Vaccine (Vaccinia Virus, live) | ACAM2000® | Sma | EPDG |
| Smallpox and Monkeypox Vaccine Modified Vaccinia Ankara-Bavarian Nordic® (live-attenuated, non-replicating) | IMVAMUNE® | SMV | BN |
| Tetanus and Diphtheria Toxoids Adsorbed | Td ADSORBED | Td | SP |
| Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed | Adacel® | Tdap | SP |
| Combined diphtheria, tetanus, acellular pertussis (adsorbed) vaccine for booster vaccination | BOOSTRIX® | GSK | |
| Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine | Adacel®- Polio | Tdap-IPV | SP |
| Combined diphtheria, tetanus, acellular pertussis (adsorbed) and inactivated poliomyelitis vaccine | BOOSTRIX®- POLIO | GSK | |
| Salmonella typhi Vi Capsular Polysaccharide Vaccine | Typhim Vi® | Typh-I | SP |
| Typhoid vaccine live oral attenuated TY21A | Vivotif® | Typh-O | ETH |
| Varicella virus vaccine, live, attenuated (Oka-strain) | VARILRIX® | Var | GSK |
| Varicella virus vaccine, live, attenuated [Oka/Merck] | VARIVAX® III | Merck | |
| Yellow Fever | YF-Vax® | YF | SP |
| Herpes Zoster vaccine (non-live recombinant) | Shingrix® | RZV | GSK |
Acronyms:
|
|||
Page details
- Date modified: